课题基金 / 基金详情

Basic approach for good prescribing: Post-translational modulation of activities of drug-metabolizing enzymes

Basic approach for good prescribing: Post-translational modulation of activities of drug-metabolizing enzymes
良好处方的基本方法:药物代谢酶活性的翻译后调节
批准号:
17590128
负责人:
ISHII Yuji
金额:
$2.3万
依托单位:
依托单位国家:
日本
项目类别:
Grant-in-Aid for Scientific Research (C)
财政年份:
2005
资助国家:
日本
项目状态:
已结题
起止时间:
2005 至 2006

项目摘要

项目成果

ISHII Yuji的其他基金

相似基金

相关文献

中文摘要
翻译
对药物代谢酶的翻译后调控进行了研究。以下是该项目的成果。1)CYP1A2和CYP2C9具有修饰UGT2B7功能的能力。然而,这些P450调节UGT2B7功能的机制(S)似乎不同于CYP3A4。2)通过免疫沉淀法、重叠实验和交联剂1-乙基-3-[3-(二甲氨基)丙基]碳二亚胺(EDC)的交联,证明了更详细的CYP3A4-UGT2B7结合。3)确定了在与UGT2B7相互作用中起作用的CYP3A4候选区域。4)酮康唑对吗啡UGT的抑制作用是通过竞争性抑制和非竞争性抑制两种新机制实现的。5)P450-UGT在大鼠中也存在相关性。有人认为这种相互作用在不同物种之间是保守的。6)酰基-COAS是UGT的内源性激活剂。7)内质网中存在许多细胞核苷酸调节UGT功能。此外,这些物质结合到UGT上的一个共同变构位置上,从而降低了催化功能。这些结果表明,P450和UGT之间存在功能上的相互作用。此外,内源性调节剂对UGT可能也很重要。在体内,CYP3A4和UGT2B7之间的相互作用对UGT2B7催化的反应的影响还有待进一步研究。
英文摘要
Post-translational modulation of activities of drug-metabolizing enzymes was studied. Followings are outcomes from this project. 1) CYP1A2 and CYP2C9 have ability to modify UGT2B7 function. However, the mechanism(s) underlying the modulation of UGT2B7 function by these P450s seems to differ from that by CYP3A4. 2) CYP3A4-UGT2B7 association was demonstrated in more detail by means of immunoprecipitation, overlay assay and cross-linking with a cross-linker, 1-ethyl-3-[3- (dimethylamino)propyl]carbodiimide (EDC). 3) The candidate region of CYP3A4 which plays a role in the interaction with UGT2B7 was determined. 4) Ketoconazole exerts its inhibitory effect on morphine UGT by novel mechanisms involving competitive and noncompetitive inhibition. 5) P450-UGT association was also found in rats. It was suggested that such interaction is conserved from species to species. 6) Acyl-CoAs play a role as an endogenous activator of UGTs. 7) A number of cellular nucleotides present within the endoplasmic reticulum regulate UGT function. Further these substances bind to a common allosteric site on UGT to reduce catalytic function.These results suggest that there are functional interaction between P450 and UGT. In addition, endogenous modulators may also important for UGT. Further study is necessary to clarify the impact of interaction between CYP3A4 and UGT2B7 on UGT2B7-catalyzed reaction in vivo.
期刊论文(9)
专著(0)
科研奖励(0)
会议论文
Fatty acyl-CoA as an endogenous activator of UDP-glucuronosyltransferases
脂肪酰辅酶A作为UDP-葡萄糖醛酸基转移酶的内源性激活剂
DOI: --
发表时间: 2006
期刊: Biochem. Biophys. Res. Commn. 345
影响因子: --
作者: [Okamura, et al]
通讯作者: et al
DOI: 10.1248/bpb.28.2026
发表时间: 2005-10-01
期刊: BIOLOGICAL & PHARMACEUTICAL BULLETIN
影响因子: 2
作者: [Takeda, S, Ishii, Y, Yamada, H]
通讯作者: Yamada, H
Bas i s stud i es on the appropr i ate usage of c l i n i ca I med i c i ne : i so form specificity of the functional interaction between drug metabolizing enzymes and the individual differences
  • 批准号:
    21590164
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.91万
  • 财政年份:
    2009
  • 负责人:
    ISHII Yuji
  • 依托单位:
Basic Studies on the appropriate usage of clinical narcotics : the individual differences in the formation of morphine active metabolite which is not dependent on the genetic polymorphism
  • 批准号:
    19590147
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $3.0万
  • 财政年份:
    2007
  • 负责人:
    ISHII Yuji
  • 依托单位:
Significance of inflammatory mediators in hepatocellular carcinoma
  • 批准号:
    18591525
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.53万
  • 财政年份:
    2006
  • 负责人:
    ISHII Yuji
  • 依托单位:
Clinical Application of Anti-angiogenetic Therapy on Hepatocarcinogenesis and Hepatocellular carcinoma -With Special Reference to Matrix Metalloproteinases and Cytokines network-
  • 批准号:
    12671268
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
  • 资助金额:
    $2.11万
  • 财政年份:
    2000
  • 负责人:
    ISHII Yuji
  • 依托单位:
国内基金
海外基金
MYB/CsATL15-UGT调控茶树黄酮醇苷合成的机制解析
柑桔全爪螨UGT202A7过表达介导阿维菌素抗性的分子调控机制
  • 批准号:
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    袁国瑞
  • 依托单位:
UGT1A1基因启动子区甲基化调控神经元铁死亡水平影响新生儿高胆 红素血症脑损伤的分子机制研究
平滑肌细胞内源性CSE/H2S通过Ugt1a6调节线粒体功能参与动脉硬化的分子机制
  • 批准号:
    82370448
  • 项目类别:
    面上项目
  • 资助金额:
    49.00万元
  • 批准年份:
    2023
  • 负责人:
    耿彬
  • 依托单位: